Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, announces the acquisition of Alerje’s mobile device integrated auto-injector platform, including its intellectual property portfolio and related physical assets. The acquired platform represents nearly a decade of award-winning innovation and product development at Alerje. “This platform is technically sound, IP secured, and commercially relevant,” said Elizabeth Reczek, PhD, CEO of Sempresto. “With Sempresto’s expertise, capital, and clarity of purpose, we are well positioned to accelerate final development and deliver this life saving innovation to patients who need it most.”
Read the full article: Sempresto Acquires Alerje’s Autoinjector Platform to Accelerate Commercialization of Smartphone Integrated Rescue Medications //
Source: https://www.businesswire.com/news/home/20251204523180/en/Sempresto-Acquires-Alerjes-Autoinjector-Platform-to-Accelerate-Commercialization-of-Smartphone-Integrated-Rescue-Medications